These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22092624)

  • 1. The effect of pimobendan on left atrial pressure in dogs with mitral valve regurgitation.
    Suzuki S; Fukushima R; Ishikawa T; Hamabe L; Aytemiz D; Huai-Che H; Nakao S; Machida N; Tanaka R
    J Vet Intern Med; 2011; 25(6):1328-33. PubMed ID: 22092624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of furosemide on left atrial pressure in dogs with mitral valve regurgitation.
    Suzuki S; Ishikawa T; Hamabe L; Aytemiz D; Huai-Che H; Fukushima R; Machida N; Tanaka R
    J Vet Intern Med; 2011; 25(2):244-50. PubMed ID: 21314718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effect of carperitide and furosemide on left atrial pressure in dogs with experimentally induced mitral valve regurgitation.
    Suzuki S; Fukushima R; Yamamoto Y; Ishikawa T; Hamabe L; Kim S; Yoshiyuki R; Fukayama T; Machida N; Tanaka R
    J Vet Intern Med; 2013; 27(5):1097-104. PubMed ID: 23952288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of amlodipine and benazepril on left atrial pressure in dogs with experimentally-induced mitral valve regurgitation.
    Suzuki S; Fukushima R; Ishikawa T; Yamamoto Y; Hamabe L; Kim S; Yoshiyuki R; Machida N; Tanaka R
    BMC Vet Res; 2012 Sep; 8():166. PubMed ID: 22989022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of angiotensin-converting enzyme inhibitors of left atrial pressure in dogs with mitral valve regurgitation.
    Ishikawa T; Tanaka R; Suzuki S; Miyaishi Y; Akagi H; Iino Y; Fukushima R; Yamane Y
    J Vet Intern Med; 2010; 24(2):342-7. PubMed ID: 20102507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a sustained-release form of isosorbide dinitrate on left atrial pressure in dogs with experimentally induced mitral valve regurgitation.
    Yamamoto Y; Suzuki S; Hamabe L; Aytemiz D; Huai-Che H; Kim S; Yoshiyuki R; Fukayama T; Fukushima R; Tanaka R
    J Vet Intern Med; 2013; 27(6):1421-6. PubMed ID: 24010635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of high-dose alacepril on left atrial pressure and central aortic pressure in awake dogs with mitral valve regurgitation.
    Goya S; Wada T; Shimada K; Hirao D; Tanaka R
    Vet J; 2019 Mar; 245():7-11. PubMed ID: 30819428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic estimation of left atrial pressure in beagle dogs with experimentally-induced mitral valve regurgitation.
    Ishikawa T; Fukushima R; Suzuki S; Miyaishi Y; Nishimura T; Hira S; Hamabe L; Tanaka R
    J Vet Med Sci; 2011 Aug; 73(8):1015-24. PubMed ID: 21483182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial.
    Boswood A; Häggström J; Gordon SG; Wess G; Stepien RL; Oyama MA; Keene BW; Bonagura J; MacDonald KA; Patteson M; Smith S; Fox PR; Sanderson K; Woolley R; Szatmári V; Menaut P; Church WM; O'Sullivan ML; Jaudon JP; Kresken JG; Rush J; Barrett KA; Rosenthal SL; Saunders AB; Ljungvall I; Deinert M; Bomassi E; Estrada AH; Fernandez Del Palacio MJ; Moise NS; Abbott JA; Fujii Y; Spier A; Luethy MW; Santilli RA; Uechi M; Tidholm A; Watson P
    J Vet Intern Med; 2016 Nov; 30(6):1765-1779. PubMed ID: 27678080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pimobendan for mitral valve regurgitation in dogs.
    Kanno N; Kuse H; Kawasaki M; Hara A; Kano R; Sasaki Y
    J Vet Med Sci; 2007 Apr; 69(4):373-7. PubMed ID: 17485924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pimobendan on echocardiographic values in dogs with asymptomatic mitral valve disease.
    Ouellet M; Bélanger MC; Difruscia R; Beauchamp G
    J Vet Intern Med; 2009; 23(2):258-63. PubMed ID: 19143935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
    Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Ablad B; Bussadori CM; Glaus T; Kovacević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir AV; O'Sullivan ML; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
    J Vet Intern Med; 2008; 22(5):1124-35. PubMed ID: 18638016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pimobendan and N-terminal probrain natriuretic peptide in the treatment of pulmonary hypertension secondary to degenerative mitral valve disease in dogs.
    Atkinson KJ; Fine DM; Thombs LA; Gorelick JJ; Durham HE
    J Vet Intern Med; 2009; 23(6):1190-6. PubMed ID: 19780931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily rhythms of left atrial pressure in beagle dogs with mitral valve regurgitation.
    Ishikawa T; Tanaka R; Suzuki S; Saida Y; Soda A; Fukushima R; Yamane Y
    J Vet Intern Med; 2009; 23(4):824-31. PubMed ID: 19496915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
    Häggström J; Lord PF; Höglund K; Ljungvall I; Jöns O; Kvart C; Hansson K
    J Vet Intern Med; 2013; 27(6):1452-62. PubMed ID: 24128373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: a prospective, controlled, blinded, and randomized study.
    Chetboul V; Lefebvre HP; Sampedrano CC; Gouni V; Saponaro V; Serres F; Concordet D; Nicolle AP; Pouchelon JL
    J Vet Intern Med; 2007; 21(4):742-53. PubMed ID: 17708394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
    Häggström J; Boswood A; O'Grady M; Jöns O; Smith S; Swift S; Borgarelli M; Gavaghan B; Kresken JG; Patteson M; Åblad B; Bussadori CM; Glaus T; Kovačević A; Rapp M; Santilli RA; Tidholm A; Eriksson A; Belanger MC; Deinert M; Little CJ; Kvart C; French A; Rønn-Landbo M; Wess G; Eggertsdottir A; Lynne O'Sullivan M; Schneider M; Lombard CW; Dukes-McEwan J; Willis R; Louvet A; DiFruscia R
    J Vet Intern Med; 2013; 27(6):1441-51. PubMed ID: 24010489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease.
    Sarcinella F; Neves J; Maddox TW; Hodgkiss-Geere HM; Bode EF; Dukes-McEwan J
    Open Vet J; 2020 Jan; 9(4):375-383. PubMed ID: 32042661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure.
    Mizuno M; Yamano S; Chimura S; Hirakawa A; Takusagawa Y; Sawada T; Maetani S; Takahashi A; Mizuno T; Harada K; Shinoda A; Uchida S; Takeuchi J; Mizukoshi T; Endo M; Uechi M
    J Vet Med Sci; 2017 Jan; 79(1):29-34. PubMed ID: 27644192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effect of pimobendan and furosemide on the circulating renin-angiotensin-aldosterone system in healthy dogs.
    Sayer MB; Atkins CE; Fujii Y; Adams AK; DeFrancesco TC; Keene BW
    J Vet Intern Med; 2009; 23(5):1003-6. PubMed ID: 19737179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.